Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Sarfe Pharms Drug Patent Portfolio

Sarfe Pharms owns 1 orange book drug protected by 1 US patent Given below is the list of Sarfe Pharms's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10154963 Controlled-release formulations comprising Torsemide 06 Oct, 2033
Active


Given below is the list of recent legal activities going on the following drug patents of Sarfe Pharms.

Activity Date Patent Number
Patent litigations
Surcharge for late Payment, Small Entity 17 Aug, 2022 US10154963
Payment of Maintenance Fee, 4th Yr, Small Entity 17 Aug, 2022 US10154963
Maintenance Fee Reminder Mailed
Critical
08 Aug, 2022 US10154963
Change in Power of Attorney (May Include Associate POA)
Critical
17 Sep, 2021 US10154963
Correspondence Address Change
Critical
15 Sep, 2021 US10154963
Patent Issue Date Used in PTA Calculation
Critical
18 Dec, 2018 US10154963
Recordation of Patent Grant Mailed
Critical
18 Dec, 2018 US10154963
Email Notification
Critical
29 Nov, 2018 US10154963
Issue Notification Mailed
Critical
28 Nov, 2018 US10154963
Application Is Considered Ready for Issue
Critical
14 Nov, 2018 US10154963
Dispatch to FDC 14 Nov, 2018 US10154963
Issue Fee Payment Received
Critical
13 Nov, 2018 US10154963
Issue Fee Payment Verified
Critical
13 Nov, 2018 US10154963
Supplemental Papers - Oath or Declaration 12 Nov, 2018 US10154963
Workflow - Drawings Finished 29 Oct, 2018 US10154963


Sarfe Pharms's Family Patents

Sarfe Pharms drugs have patent protection in a total of 2 countries. It has a significant patent presence in the US with 88.9% of its patents being US patents. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Sarfe Pharms Drug List

Given below is the complete list of Sarfe Pharms's drugs and the patents protecting them.


1. Soaanz

Soaanz is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10154963 Controlled-release formulations comprising Torsemide 06 Oct, 2033
(7 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Soaanz's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List